CRL Q3 2016 Earnings Report — Charles River Laboratories International, Inc. Revenue & Financial Results | Market Cap Arena

Charles River Laboratories International, Inc.CRL

Q3 2016 Earnings

Reported November 2, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2016	Q2 2016	Q3 2015	QoQ Change	YoY Change
Revenue	$426M	—	—	—	—
Op. Income	$59M	—	—	—	—
Gross Margin	36.7%	—	—	—	—
Net Margin	8.9%	—	—	—	—
EPS (Diluted)	$0.79	—	—	—	—
Free Cash Flow	$59M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$426M
Cost of Revenue	$269M
GROSS PROFIT	$156M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$86M
Other Expenses	$12M
Operating Expenses	$97M
Cost & Expenses	$367M
OPERATING INCOME	$59M
Interest Income	$523.0K
Interest Expense	$7M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$53M
Income Tax Expense	$16M
Net Income from Continuing Ops	$38M
Net Income from Discontinued Ops	$342.0K
Other Adjustments	$0
NET INCOME	$38M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$38M
D&A	$34M
EBIT	$60M
EBITDA	$94M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$426M
Cost of Revenue	$269M
GROSS PROFIT	$156M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$86M
Other Expenses	$12M
Operating Expenses	$97M
Cost & Expenses	$367M
OPERATING INCOME	$59M
Interest Income	$523.0K
Interest Expense	$7M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$53M
Income Tax Expense	$16M
Net Income from Continuing Ops	$38M
Net Income from Discontinued Ops	$342.0K
Other Adjustments	$0
NET INCOME	$38M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$38M
D&A	$34M
EBIT	$60M
EBITDA	$94M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$38M
Depreciation & Amortization	$34M
Stock-Based Compensation	$11M
Deferred Income Tax	$2M
Other Non-Cash Items	$5M
Change in Working Capital	-$20M
OPERATING CASH FLOW	$69M
Capital Expenditure	-$10M
Acquisitions (Net)	-$19M
Purchases of Investments	-$2M
Sales/Maturities of Investments	$20M
Other Investing Activities	-$284.0K
NET CASH FROM INVESTING	-$11M
Net Debt Issuance	-$107M
Common Stock Repurchased	-$28.0K
Common Dividends Paid	$0
Other Financing Activities	$1M
NET CASH FROM FINANCING	-$105M
FREE CASH FLOW	$59M
Net Change in Cash	-$49M

Balance Sheet

Item	Amount
Cash & Equivalents	$106M
Short-Term Investments	$8M
Net Receivables	$360M
Inventory	$99M
Other Current Assets	$720.0K
TOTAL CURRENT ASSETS	$655M
PP&E (Net)	$767M
Goodwill	$764M
Intangible Assets	$396M
Long-Term Investments	$46M
Tax Assets	$22M
Other Non-Current Assets	$41M
TOTAL NON-CURRENT ASSETS	$2.0B
TOTAL ASSETS	$2.7B
Account Payables	$66M
Short-Term Debt	$26M
Deferred Revenue	$119M
Other Current Liabilities	$83M
TOTAL CURRENT LIABILITIES	$412M
Long-Term Debt	$1.2B
Deferred Revenue NC	$70M
Deferred Tax Liabilities	$54M
Other Non-Current Liabilities	$75M
TOTAL NON-CURRENT LIABILITIES	$1.4B
TOTAL LIABILITIES	$1.8B
Common Stock	$863.0K
Additional Paid-In Capital	$2.5B
Retained Earnings	$121M
Treasury Stock	-$1.6B
Accum. Other Comp. Income	-$166M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$868M
Minority Interest	$20M
TOTAL EQUITY	$888M
TOTAL LIABILITIES & EQUITY	$2.7B
Total Debt	$1.3B
Net Debt	$1.2B